Cyclosporine A + Dexamethasone
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Vernal Keratoconjunctivitis
Conditions
Vernal Keratoconjunctivitis
Trial Timeline
Jul 1, 2008 → Nov 1, 2008
NCT ID
NCT01211327About Cyclosporine A + Dexamethasone
Cyclosporine A + Dexamethasone is a approved stage product being developed by Novartis for Vernal Keratoconjunctivitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01211327. Target conditions include Vernal Keratoconjunctivitis.
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01211327 | Approved | Completed |